Descriptive Study of Recombinant Human Insulin-Like Growth Factor for Osteoporosis in Werner's Syndrome

National Center for Research Resources (NCRR)0 个研究点目标入组 1 人开始时间: 1992年5月1日最近更新: 2005年6月24日

适应症

试验速览

阶段: 不适用
状态: 已完成
发起方
入组人数: 1

研究概览研究设计入排标准研究者记录与标识符相似试验

研究概览

简要总结

OBJECTIVES:

I. Assess the safety and efficacy of recombinant human insulin-like growth factor 1 in a patient with Werner's syndrome and osteoporosis.

详细描述

PROTOCOL OUTLINE: The patient receives subcutaneous recombinant human insulin-like growth factor 1 daily for 7 months. The dose is adjusted according to the serum hormone level and biological markers of bone turnover.

Concurrent therapy includes a metabolic diet, calcium citrate, and estradiol.

研究设计

研究类型: Interventional
分配方式: Non Randomized
主要目的: Treatment

入排标准

年龄范围: 0 Years 至 —（Child, Adult, Older Adult）
性别: All
接受健康志愿者: 否

入选标准

•PROTOCOL ENTRY CRITERIA:
•-Disease Characteristics-- Werner's syndrome with osteoporosis and low serum insulin-like growth factor 1 level Patient treated on protocol 04-9215300 "Metabolic and Skeletal Effects of Exogenous Recombinant Human Insulin-Like Growth Factor"

排除标准

未提供

研究者

发起方

National Center for Research Resources (NCRR)

申办方类型

Nih

相似试验

已完成

不适用

Study of Recombinant Human Insulin-Like Growth Factor I in Patients With Severe Insulin ResistanceInsulin ResistanceHyperglycemia

NCT00004419Beth Israel Deaconess Medical Center18

已完成

不适用

Short Term Study of Recombinant Human Insulin-like Growth Factor I in Children With HyperinsulinismHyperinsulinism

NCT00004825FDA Office of Orphan Products Development10

已完成

2 期

Recombinant Human Insulin-Like Growth Factor (rhIGF-1) Treatment of Short Stature Associated With IGF-1 DeficiencyInsulin-Like Growth Factor-1 DeficiencyGrowth Disorders

NCT00125190Ipsen45

已完成

2 期

Phase II Long Term, Randomized Study of Recombinant Human Insulin-like Growth Factor I in Children With HyperinsulinismHyperinsulinism

NCT00004700Children's Hospital of Philadelphia16

Unknown

4 期

Efficacy and Safety of Recombinant Human Insulin Patch ZJSRM2021type1diabetesType2 Diabetes

NCT05089942Zhejiang Provincial People's Hospital16